FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281287789> ?p ?o ?g. }

• W4281287789 endingPage "1588" @default.
• W4281287789 startingPage "1577" @default.
• W4281287789 abstract "Glucocorticoids are potent immunosuppressive and anti-inflammatory drugs used for various systemic and localized conditions. The use of glucocorticoids needs to be weighed against their adverse effect of aggravating hyperglycemia in persons with diabetes mellitus, unmask undiagnosed diabetes mellitus, or precipitate glucocorticoid-induced diabetes mellitus appearance. Hyperglycemia is associated with poor clinical outcomes, including infection, disability after hospital discharge, prolonged hospital stay, and death. Furthermore, clear guidelines for managing glucocorticoid-induced hyperglycemia are lacking. Therefore, this consensus document aims to develop guidance on the management of glucocorticoid-induced hyperglycemia. Twenty expert endocrinologists, in a virtual meeting, discussed the evidence and practical experience of real-life management of glucocorticoid-induced hyperglycemia. The expert group concluded that we should be proactive in terms of diagnosis, management, and post-steroid care. Since every patient has different severity of underlying disease, clinical stratification would help understand patient profiles and determine the treatment course. Patients at home with pre-existing diabetes who are already on oral or injectable therapy can continue the same as long as they are clinically stable and eating adequately. However, depending on the degree of hyperglycemia, modification of doses may be required. Initiating basal bolus with correction regimen is recommended for patients in non-intensive care unit settings. For patients in intensive care unit, variable rate intravenous insulin infusion could be temporarily used, but under supervision of diabetes inpatient team, and patients can be transitioned to subcutaneous insulin once stable baseline assessment and continual evaluation are crucial for day-to-day decisions concerning insulin doses. Glycemic variability should be carefully monitored, and interventions to treat patients should also aim at achieving and maintaining euglycemia. Rational use of glucose-lowering drugs is recommended and treatment regimen should ensure maximum safety for both patient and provider. Glucovigilance is required as the steroids taper during transition, and insulin dosage should be reduced subsequently. Increased clinical and economic burden resulting from corticosteroid-related adverse events highlights the need for effective management. Therefore, these recommendations would help successfully manage GC-induced hyperglycemia and judiciously allocate resources." @default.
• W4281287789 created "2022-05-24" @default.
• W4281287789 creator A5004136183 @default.
• W4281287789 creator A5007658785 @default.
• W4281287789 creator A5009174186 @default.
• W4281287789 creator A5013749155 @default.
• W4281287789 creator A5017520150 @default.
• W4281287789 creator A5019109422 @default.
• W4281287789 creator A5020152686 @default.
• W4281287789 creator A5030397582 @default.
• W4281287789 creator A5034662952 @default.
• W4281287789 creator A5036077500 @default.
• W4281287789 creator A5064916236 @default.
• W4281287789 creator A5065327601 @default.
• W4281287789 creator A5068474732 @default.
• W4281287789 creator A5070975593 @default.
• W4281287789 creator A5071764749 @default.
• W4281287789 creator A5072626371 @default.
• W4281287789 creator A5073286165 @default.
• W4281287789 creator A5084118223 @default.
• W4281287789 creator A5087160190 @default.
• W4281287789 creator A5088408186 @default.
• W4281287789 date "2022-05-01" @default.
• W4281287789 modified "2023-09-29" @default.
• W4281287789 title "Management of Glucocorticoid-Induced Hyperglycemia" @default.
• W4281287789 cites W106496334 @default.
• W4281287789 cites W1178610922 @default.
• W4281287789 cites W1970267506 @default.
• W4281287789 cites W1981302261 @default.
• W4281287789 cites W1994054225 @default.
• W4281287789 cites W1995192924 @default.
• W4281287789 cites W1997116821 @default.
• W4281287789 cites W2005103084 @default.
• W4281287789 cites W2006120678 @default.
• W4281287789 cites W2007003907 @default.
• W4281287789 cites W2018850250 @default.
• W4281287789 cites W2029887637 @default.
• W4281287789 cites W2034055449 @default.
• W4281287789 cites W2037421018 @default.
• W4281287789 cites W2055402251 @default.
• W4281287789 cites W2057624928 @default.
• W4281287789 cites W2059241568 @default.
• W4281287789 cites W2072585011 @default.
• W4281287789 cites W2073246412 @default.
• W4281287789 cites W2075837852 @default.
• W4281287789 cites W2097582258 @default.
• W4281287789 cites W2114348148 @default.
• W4281287789 cites W2115424310 @default.
• W4281287789 cites W2137953708 @default.
• W4281287789 cites W2141351444 @default.
• W4281287789 cites W2149347361 @default.
• W4281287789 cites W2154889019 @default.
• W4281287789 cites W2158343755 @default.
• W4281287789 cites W2172218994 @default.
• W4281287789 cites W2177119636 @default.
• W4281287789 cites W2202533336 @default.
• W4281287789 cites W2409510002 @default.
• W4281287789 cites W2596204468 @default.
• W4281287789 cites W2729366780 @default.
• W4281287789 cites W2753718881 @default.
• W4281287789 cites W2770574068 @default.
• W4281287789 cites W2770616601 @default.
• W4281287789 cites W2884902719 @default.
• W4281287789 cites W3090485327 @default.
• W4281287789 cites W3111430313 @default.
• W4281287789 cites W3127246796 @default.
• W4281287789 cites W4238714725 @default.
• W4281287789 doi "https://doi.org/10.2147/dmso.s330253" @default.
• W4281287789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35637859" @default.
• W4281287789 hasPublicationYear "2022" @default.
• W4281287789 type Work @default.
• W4281287789 citedByCount "7" @default.
• W4281287789 countsByYear W42812877892022 @default.
• W4281287789 countsByYear W42812877892023 @default.
• W4281287789 crossrefType "journal-article" @default.
• W4281287789 hasAuthorship W4281287789A5004136183 @default.
• W4281287789 hasAuthorship W4281287789A5007658785 @default.
• W4281287789 hasAuthorship W4281287789A5009174186 @default.
• W4281287789 hasAuthorship W4281287789A5013749155 @default.
• W4281287789 hasAuthorship W4281287789A5017520150 @default.
• W4281287789 hasAuthorship W4281287789A5019109422 @default.
• W4281287789 hasAuthorship W4281287789A5020152686 @default.
• W4281287789 hasAuthorship W4281287789A5030397582 @default.
• W4281287789 hasAuthorship W4281287789A5034662952 @default.
• W4281287789 hasAuthorship W4281287789A5036077500 @default.
• W4281287789 hasAuthorship W4281287789A5064916236 @default.
• W4281287789 hasAuthorship W4281287789A5065327601 @default.
• W4281287789 hasAuthorship W4281287789A5068474732 @default.
• W4281287789 hasAuthorship W4281287789A5070975593 @default.
• W4281287789 hasAuthorship W4281287789A5071764749 @default.
• W4281287789 hasAuthorship W4281287789A5072626371 @default.
• W4281287789 hasAuthorship W4281287789A5073286165 @default.
• W4281287789 hasAuthorship W4281287789A5084118223 @default.
• W4281287789 hasAuthorship W4281287789A5087160190 @default.
• W4281287789 hasAuthorship W4281287789A5088408186 @default.
• W4281287789 hasBestOaLocation W42812877891 @default.
• W4281287789 hasConcept C126322002 @default.
• W4281287789 hasConcept C134018914 @default.

• next